Delivery Order SPE2DE21D0005-SPE2D625F7DY0
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,274.00 to Organogenesis Inc. for the supply of PURAPLY Micronized 500mg, an advanced wound care product. The contract, awarded on July 23, 2025, with an ultimate completion date of July 28, 2025, utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. Organogenesis, a regenerative medicine company headquartered in Canton, Massachusetts, will perform the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
- This is a delivery order contract awarded to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of PURAPLY MICRONIZED, 500MG, a wound care product, with a ceiling value of $3,008. The contract has a fixed price with economic price adjustment pricing type and a completion date of June 10, 2025. Organogenesis is a key supplier of medical products, including skin substitutes,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
- This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company, to provide PURAPLY AM wound dressings. The order is part of a larger $49.5 million multiple-award indefinite delivery contract (IDC) that Organogenesis holds with DLA for wound care dressings, discs, and other medical materials through May 2026. Organogenesis also maintains Blanket Purchase Agreements valued up to $7 million...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment, with a completion date of March 20, 2025. The contract does not have a set-aside...
- This is a $3,400 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is for the supply of PURAPLY AM XT EF, a 5-layer fenestrated wound dressing product, with an ultimate completion date of July 3, 2025. Organogenesis is an established federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA)...
- This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order is for PURAPLY AM wound care dressings, which are advanced skin substitutes used to support tissue repair and regeneration. Organogenesis is an experienced federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $2,088.00 for PURAPLY Micronized, 500mg on July 31, 2025, with an ultimate completion date of August 5, 2025. This fixed-price contract with economic price adjustment was awarded without set-aside designation by the Defense Logistics Agency's Medical Supply Chain division. PURAPLY Micronized is an advanced wound care product utilized in regenerative medicine...
- This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
- SPE2DE21D0005Indefinite Delivery Contract
- SPE2DE21D0005-SPE2D625F7DY0Delivery Order
This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,504.00 contract is for the supply of PURAPLY MICRONIZED, 500MG, a specialized medical product used for advanced wound care. The award has an ultimate completion date of July 21, 2025. Organogenesis is a for-profit manufacturer that holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at $25 million, $30 million, and $49.5 million, respectively. These contract vehicles enable Organogenesis to provide a range of regenerative medicine solutions, including wound care dressings and surgical implants, to support medical treatments for military personnel and veterans. The current delivery order does not utilize a set-aside designation, indicating Organogenesis competes as a standard commercial vendor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/16/25 |